Medical Marijuana and Pregnancy: What the Research Says

As medical marijuana becomes more accessible in Florida, pregnant patients and those planning pregnancy increasingly ask about cannabis safety during pregnancy and breastfeeding. This is a topic where we must be guided by the best available evidence and the positions of major medical organizations — even when that evidence is incomplete. This article provides an honest, evidence-based overview of what we know, what we don't know, and what the medical consensus currently recommends.

What Major Medical Organizations Say

The position of major medical organizations is clear and consistent: the American College of Obstetricians and Gynecologists (ACOG), the American Academy of Pediatrics (AAP), and the Centers for Disease Control and Prevention (CDC) all recommend against cannabis use during pregnancy and breastfeeding. These recommendations are based on the precautionary principle — given the potential for harm and the availability of alternative treatments, the safest course is avoidance during pregnancy.

What the Research Shows

THC crosses the placental barrier and can reach the developing fetus. Studies have associated prenatal cannabis exposure with lower birth weight, preterm birth, and potential effects on neurodevelopment — though these findings are complicated by confounding factors (co-use of tobacco, alcohol, or other substances, socioeconomic factors, and the difficulty of studying illegal substance use). CBD research during pregnancy is even more limited, and most medical professionals advise against CBD use during pregnancy as well due to insufficient safety data. It's important to note that the endocannabinoid system plays a role in embryonic development, placental function, and fetal brain development — which is why exogenous cannabinoids are a theoretical concern.

Cannabis Use During Breastfeeding

THC is lipophilic (fat-soluble) and accumulates in breast milk. Studies have detected THC in breast milk for up to six days after use, and because infants have immature metabolic systems, they process THC much more slowly than adults. The AAP recommends that breastfeeding mothers avoid cannabis use entirely. For mothers who use cannabis and wish to breastfeed, the decision involves weighing the benefits of breastfeeding against the potential risks of THC exposure — a conversation best had with your obstetrician or pediatrician.

What Should Patients Do?

If you are pregnant, planning to become pregnant, or breastfeeding, the current medical consensus is to avoid cannabis use — including both THC and CBD products. If you are currently using medical marijuana for a qualifying condition and become pregnant, discuss alternative treatments with your obstetrician and your certifying physician. Do not abruptly stop any treatment without medical guidance. If you are using cannabis for nausea during pregnancy (a common reason for use), discuss safer anti-nausea alternatives with your OB. If your qualifying condition is severe and alternative treatments are inadequate, have an honest conversation with both your OB and Dr. Stratt about risk-benefit considerations specific to your situation.

A Note on Evolving Research

Cannabis research during pregnancy faces significant ethical and methodological challenges — controlled trials cannot ethically expose pregnant women to substances with uncertain safety profiles. Much of the existing evidence comes from observational studies with inherent limitations. As research methods improve and more data becomes available, recommendations may evolve. For now, the precautionary approach recommended by ACOG, AAP, and CDC represents the best available guidance.